2026-01-15 - Analysis Report
# Procter & Gamble Co Financial Report
## Company Overview
Procter & Gamble Co is a multinational consumer goods corporation.

### 1. Return Rate Comparison
* Cumulative return of review stock = **22.40%**
* Cumulative return of comparison stock (S&P 500, VOO) = **92.89%**
* Divergence (max: 25.10, min: -76.90, current: -73.30, relative divergence: 3.50%)

### 2. Return Rate Analysis
* Degree of divergence = **-73.30**
* Relative divergence = **3.50%**

### 3. 5-Day, 20-Day, 60-Day Moving Average Analysis
* 5-day SMA = **$143.49**
* 20-day SMA = **$143.38**
* 60-day SMA = **$145.96**

### 4. RSI, PPO Index Indicators Analysis
* Market Risk Indicator (MRI) = **0.70**
* RSI = **59.57**
* PPO = **0.34**
* Hybrid Signal:
	+ Buy (Cash 0%)
	+ Risk Level: Medium (MRI 0.70)
* Recent (20 days) relative divergence change = **3.50 (+): improving**
* 7-day Rank change = **-39 (-): rank down**
* 7-day Dynamic Expected Return change = **-15.00 (-): worsening**
* Expected Return (%) = **4.20%,** Expected excess return compared to S&P 500 if invested long-term (more than 2 years) from this point.

### 5. Recent News and Significant Events
* Recent headlines:
	+ "Procter & Gamble (NYSE:PG) Stock Price Up 1.4% Following Dividend Announcement"
	+ "UBS Lowers Price Target for PG, Maintains Buy Rating"
	+ "2 No-Brainer Dividend Stocks to Buy Right Now"
	+ "TD Cowen is Bullish on The Procter & Gamble Company (PG)"
	+ "Procter & Gamble: A Buying Strategy For The Dividend Stock (NYSE:PG)"

### 6. Recent Analyst Opinions
```text
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.00 (~Buy)
- Opinions: 22
- Target Price (avg/high/low): 165.50 / 186.00 / 148.00
```

### 7. Recent Earnings Analysis
| Quarter | EPS | Revenue |
|---------|-----|----------|
| 2025-10-24 | $2 | $22.39 B$ |
| 2025-04-24 | $1.58 | $19.78 B$ |
| 2025-01-22 | $1.94 | $21.88 B$ |
| 2024-10-18 | $1.65 | $21.74 B$ |

* Recent quarter's revenue and EPS are strong, but with fluctuations.

### 8. Financial Information Analysis
* Revenue and Profitability:
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $22.39B | 51.37% |
| 2025-06-30 | $20.89B | 49.11% |
| 2025-03-31 | $19.78B | 50.98% |
| 2024-12-31 | $21.88B | 52.39% |
| 2024-09-30 | $21.74B | 52.06% |

* Revenue has been fluctuating, but profit margin remains relatively stable.

* Capital and Profitability:
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $53.27B | 8.92% |
| 2025-06-30 | $52.01B | 6.95% |
| 2025-03-31 | $52.27B | 7.21% |
| 2024-12-31 | $51.17B | 9.05% |
| 2024-09-30 | $51.84B | 7.64% |

* Equity has been stable, but ROE has fluctuated.

### 9. Comprehensive Analysis
Procter & Gamble Co has a stable financial condition with strong revenue and profit margins. However, there are fluctuations in equity and ROE. Recent analyst opinions are positive, but with fluctuations. Overall, the company's financial performance is relatively stable.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.